Premium
Fecal microbiota signatures of adult patients with different types of short bowel syndrome
Author(s) -
Huang Yuhua,
Guo Feilong,
Li Yousheng,
Wang Jian,
Li Jieshou
Publication year - 2017
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.13806
Subject(s) - lachnospiraceae , dysbiosis , feces , short bowel syndrome , firmicutes , gut flora , gastroenterology , lactobacillus , microbiome , medicine , irritable bowel syndrome , microbiology and biotechnology , bacteroides , bacteroidaceae , prevotella , biology , bacteria , parenteral nutrition , immunology , bioinformatics , 16s ribosomal rna , genetics
Background and Aim Short bowel syndrome (SBS) is a common cause of intestinal failure and can be divided into three types depending on intestinal anatomy. Gut dysbiosis has been observed in pediatric SBS patients and is associated with impaired outcome. Little is known about the changes in gut microbiota of adult SBS patients. Therefore, we aim to characterize the fecal microbiota of adult patients with different types of SBS. Methods Fifteen fecal samples from healthy controls and adult patients with type II or type III SBS were collected (five in each group). Fecal microbial compositions were determined by high‐throughput sequencing, and functional potential was predicted by Phylogenetic Investigation of Communities by Reconstruction of Unobserved States. Results Bacterial α ‐diversity significantly decreased in SBS patients and positively correlated to the remaining small bowel length. SBS II patients were enriched with Proteobacteria but deficient in Firmicutes and Bacteroidetes. Whereas Lactobacillus and Prevotella dominated the microbiomes of SBS III patients, commensal bacteria from Lachnospiraceae, Ruminococcaceae, and Bacteroidaceae declined in SBS patients. The parenteral nutrition duration of SBS patients was positively related to the proportion of Enterobacteriaceae but negatively related to Lactobacillus . Functional pathways of citrate cycle and branched‐chain and aromatic amino acid biosynthesis were abundant in SBS II patients, while functional profiles of pyrimidine and purine metabolism were dominant in SBS III patients. Conclusions Short bowel syndrome patients have a marked intestinal dysbiosis with type II SBS characterized by Proteobacteria and type III SBS featured by Lactobacillus , resulting in altered functional profiles of fecal microbiomes.